- Home
- OVID vs ADVB Comparison
OVID vs ADVB Comparison
Compare OVID & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- ADVB
- Stock Information
- Founded
- OVID 2014
- ADVB 2014
- Country
- OVID United States
- ADVB United States
- Employees
- OVID N/A
- ADVB N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- ADVB Medical Specialities
- Sector
- OVID Health Care
- ADVB Health Care
- Exchange
- OVID Nasdaq
- ADVB Nasdaq
- Market Cap
- OVID 20.6M
- ADVB 20.8M
- IPO Year
- OVID 2017
- ADVB 2025
- Fundamental
- Price
- OVID $0.31
- ADVB $0.69
- Analyst Decision
- OVID Strong Buy
- ADVB
- Analyst Count
- OVID 4
- ADVB 0
- Target Price
- OVID $3.13
- ADVB N/A
- AVG Volume (30 Days)
- OVID 969.8K
- ADVB 57.0K
- Earning Date
- OVID 08-12-2025
- ADVB 08-03-2025
- Dividend Yield
- OVID N/A
- ADVB N/A
- EPS Growth
- OVID N/A
- ADVB N/A
- EPS
- OVID N/A
- ADVB N/A
- Revenue
- OVID $548,000.00
- ADVB N/A
- Revenue This Year
- OVID N/A
- ADVB N/A
- Revenue Next Year
- OVID $5.32
- ADVB N/A
- P/E Ratio
- OVID N/A
- ADVB N/A
- Revenue Growth
- OVID 15.61
- ADVB N/A
- 52 Week Low
- OVID $0.24
- ADVB $0.69
- 52 Week High
- OVID $1.47
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- OVID 52.32
- ADVB N/A
- Support Level
- OVID $0.29
- ADVB N/A
- Resistance Level
- OVID $0.32
- ADVB N/A
- Average True Range (ATR)
- OVID 0.03
- ADVB 0.00
- MACD
- OVID 0.00
- ADVB 0.00
- Stochastic Oscillator
- OVID 50.50
- ADVB 0.00
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.